心不全患者の肥満管理:現在の証拠と戦略
Shriya Sharma1, Ganesh Giri2, Aarti Desai1
1Division of Advanced Heart Failure and Transplantation, Mayo Clinic in Florida.
The American journal of cardiology
|February 12, 2026
まとめ
肥満は,心不全の患者に著しく影響を及ぼし,健康上のリスクを高めます. 多分野戦略による肥満の管理は,心不全における生活の質と機能的状態を改善することができます.
科学分野:
- 心臓病学 心臓病学
- メタボリック障害 メタボリック障害
- 公衆衛生は公衆衛生である.
背景:
- 過剰な脂肪組織として定義される肥満は,世界的な主要な健康問題です.
- 糖尿病,心血管疾患,高血圧,炎症と関連しており,心不全のリスクを高めています.
- 肥満の罹患率は2035年までに著しく上昇すると予測されています.
研究 の 目的:
- 心不全患者の肥満管理に関する現在の証拠をレビューする.
- 心不全の合併症に対する肥満の影響を調査する.
- 肥満の有資格な心不全患者のための先進的な治療法の選択肢について議論する.
主な方法:
- これはレビュー記事です.
- 心不全における肥満管理に関する既存の研究を統合しています.
- それは,多学科的な治療戦略と先進的な治療法を検討します.
主要な成果:
- 肥満は,心血管疾患,インスリン抵抗性,炎症を通じて心不全を悪化させる.
- 理学療法,栄養,薬理療法,減量外科手術を含む多学科的な管理は,患者の結果を改善することができます.
- 肥満に対処することで,心不全患者の機能的状態と生活の質が向上します.
結論:
- 効果的な肥満管理は,心不全の患者にとって極めて重要です.
- 総合的なケアには,多学科的なアプローチが不可欠です.
- 心臓移植やLVADなどの高度な治療法は,終末期心不全や肥満の特定の患者に考慮されるべきである.
関連する概念動画
01:30Heart Failure V: Medical Management
363
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
363
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
01:21Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
01:17Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
01:27Heart Failure I: Introduction
958
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
958
01:22Heart Failure VI: Adjunct Therapies
399
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
399